BOSTON, Dec 13 (Reuters) - Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.



Latest News

Daily Mail: Detained Saudi activists being electrocuted, flogged and sexually harassed by masked interrogators

CNBC: If you're trading commodities, you can lose more than all your money: Kilduff

CNBC: News Update - Afternoon

Reuters: Senate Democrat vows to withhold funds to Saudi Arabia, urges sanctions

WashingtonPost: Woman claims Avenatti dragged her by arm across floor

WashingtonPost: Hollywood in the ’50s is slightly musty in ‘All Save One’

WashingtonPost: As Wizards cast aside turmoil, John Wall declares this is ‘where I want to finish my career’

FOX: Woman who died on Princess Cruises ship did not want to go on trip, her children say

CNN: Quickly catch up on the day's news

USA Today: JR Smith done in Cleveland as Cavaliers attempt to trade veteran guard

USA Today: Dead whale washed ashore with 13 pounds of plastic in its stomach

USA Today: Trump grants pardons to turkeys Peas and Carrots

USA Today: Zinke on wildfires: 'Radical' groups would rather burn down forest than thin one tree

CBC: Leaving no doubt: Olympic icon Yuzuru Hanyu has the greatest fans

BBC: Scotland v Israel: Who is impressing? And who isn't? Rate the players

ABC: Democrats intend to probe Ivanka Trump's use of personal email in next Congress

ABC: WATCH: Thanksgiving's most disliked dishes

ABC: Surging No. 7 Washington State eyes Pac-12 North title

Daily Mail: Graeme Swann criticises Cricket Australia over attempt to reduce bans for senior cricketers

CNBC: Small businesses hold key to Facebook's ad business

Reuters: U.N. environment chief quits over travel expense report

Jpost: U.S. Senate Democrat vows to withhold funds to Saudi Arabia

Haaretz: TechNation: Corporations playing increasingly big role in Israeli VC scene